Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
32 hedge funds and large institutions have $42M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
7% more funds holding
Funds holding: 30 → 32 (+2)
9% less capital invested
Capital invested by funds: $46M → $42M (-$4.02M)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
60% less call options, than puts
Call options by funds: $683K | Put options by funds: $1.69M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$2.72M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.23M |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$473K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$353K |
| 5 |
Morgan Stanley
New York
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOAM
Vertex One Asset Management
Vancouver,
British Columbia, Canada
|
-$3.2M |
| 2 |
ACM
Alistair Capital Management
Dallas,
Texas
|
-$2.62M |
| 3 |
BC
Broadfin Capital
New York
|
-$1.58M |
| 4 |
Millennium Management
New York
|
-$612K |
| 5 |
Renaissance Technologies
New York
|
-$584K |
CORV Hedge Fund Activity: Q2 2014 in Review
32 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2014, worth a combined $42M — down 8.7% from $46M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CORV positions and 5 closed out — a net gain of 2 holders — while 9 added to existing stakes and 10 trimmed.
The largest buyer was Clough Capital Partners, opening a new position worth an estimated $2.72M. The largest seller was Vertex One Asset Management, exiting entirely with an estimated $3.2M sold.
- 32 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2014, up from 30 in Q1 2014.
- Funds reported $42M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2014, down 8.7% quarter-over-quarter.
- 7 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2014 and 5 closed out, a net change of +2 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2014 was Clough Capital Partners, an estimated $2.72M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2014 was Vertex One Asset Management, an estimated $3.2M sold.
Based on aggregated 13F filings for Q2 2014.